IMBRUVICA
Identification of Imbruvica
No description |
Google image searchProduct monograph
Active ingredient
ibrutinib, 140 MG
DIN: 02434407
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JANSSEN INC
Date: 19-NOV-2014
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EL — Bruton's tyrosine kinase (BTK) inhibitors (ATC, ATC/DDD)
- L01EL01 — IBRUTINIB (ATC/DDD)
External Links for Imbruvica
Search on Google
Janssen Inc
Go to Janssen website to see drug product details. Sometimes you can find imbruvica photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.